丙型肝炎病毒(ＨＣＶ)感染不仅是导致肝脏病变,并发展至肝硬化、肝癌的常见病因,还可引起ＨＣＶ相关的肾脏疾病。在终末期肾衰患者,ＨＣＶ感染率较高,可达20%～40%。对于ＨＣＶ感染的治疗,特别是肾脏疾病合并ＨＣＶ感染的治疗,目前尚无良策,干扰素(ＩＦＮ)在治疗ＨＣＶ方面具有 Hepatitis C virus (HCV) infection is not only the cause of liver disease, and development of liver cirrhosis, a common cause of liver cancer, but also cause HCV-related kidney disease. In patients with end-stage renal failure, HCV infection rate is high, up to 20% to 40%. For the treatment of HCV infection, especially in the treatment of HCV infection with kidney disease, there is currently no good strategy for interferon (IFN) in the treatment of HCV with